|
If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | |||||||||||||||||||
  Acta Psychiatrica ScandinavicaVolume 109 Issue 1, Pages 77 - 78 Published Online: 10 Dec 2003 © 2010 John Wiley & Sons A/S
Abstract | References | Full Text: HTML, PDF (Size: 92K) | Related Articles | Citation Tracking  Case report Amphetamine-like stimulant cessation in an abusing patient treated with bupropion Copyright 2004 Blackwell Munksgaard KEYWORDS bupropion • substance • withdrawal syndrom • amphetamine • case report • human Tardieu S, Poirier Y, Micallef J, Blin O. Amphetamine-like stimulant cessation in an abusing patient treated with bupropion.
Acta Psychiatr Scand 2004: 109: 75–78. © Blackwell Munksgaard 2004. ABSTRACTObjective: Bupropion sustained release is considered to be a weak inhibitor of dopamine and serotonin reuptake. Method: We report the case of an amphetamine-abusing patient who self-administered bupropion. Results: Since 30 years, a 52-year-old women used amphetamine derivates. She explained her need for amphetamine use in order to perform daily activities. Recently, she decided to experiment with bupropion. She abruptly stopped taking clobenzorex and simultaneously started taking bupropion (150 mg/day). The seventh day she reported a concomitant intake of clobenzorex; this induced adverse effects. Whilst taking bupropion, she described experiencing an euthymic state without any compulsion to take amphetamine drugs and was able to perform daily activities. After stopping it, no symptoms of withdrawal were reported by the patient. Conclusion: This observation supports an another report suggesting that bupropion may be of help in weaning from amphetamine users and should be confirmed by clinical trials. Accepted for publication June 11, 2003 | 
|
|
| ||||||||||||||||
|
|
|||||||||||||||||||
 | Personality and Mental Health |
| |
